Hepatitis C Virus Therapy
New findings from University of Naples in the area of hepatitis C virus therapy described
Published in Blood Weekly, May 6th, 2010
New investigation results, 'Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon,' are detailed in a study published in Internal and Emergency Medicine. "Treatments for chronic hepatitis C (CHC) patients intolerant to pegylated interferons (peg-IFNs) are lacking. Thus, such patients remain at high risk of developing an advanced and decompensated liver disease," scientists in Naples, Italy report.
"Leukocyte IFN-alpha (Le-IFN-alpha) seems to possess a safer profile than other natural and recombinant a-interferons, but no information is available for peg-IFN intolerant patients. Accordingly, we...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2010-05-06)
More Articles from Blood Weekly
- World Journal of Gastroenterology
Ischemic preconditioning alters hepatic blood supply - Affymetrix, Inc.
Affymetrix Launches DNA Copy Number Service for Difficult FFPE Samples in Cancer Research - Alpha-thalassemia
Southern Medical University publishes research in alpha-thalassemia - Anemia
New findings in anemia described from Affiliated Hospital - Anemia
New research on anemia from University of Nevada summarized - Anemia
Scientists at Indiana University publish new data on anemia - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
